Risk-based decision making in rats: Modulation by sex and amphetamine

Area of Science:

• Neuroscience
• Behavioral Endocrinology
• Decision-Making Research

Background:

• Decision-making is crucial for adaptation and is modulated by gonadal hormones.
• Testosterone and estradiol may influence the mesocorticolimbic dopamine pathway, affecting choices.
• Understanding sex differences in risk-based decision-making is vital.

Purpose of the Study:

• To investigate sex differences in risk-based decision-making.
• To examine the effects of gonadal hormones (testosterone, estradiol) on risk-taking.
• To assess the impact of the dopamine agonist amphetamine on decision-making in intact and gonadectomized rats.

Main Methods:

• Male and female rats (intact or gonadectomized) performed a probabilistic discounting task.
• Hormonal effects were tested using testosterone propionate and 17β-estradiol benzoate administration.
• Amphetamine's effects were evaluated after a washout period in intact and gonadectomized rats.

Main Results:

• Males made riskier choices than females, especially at lower probabilities; gonadectomy did not affect this.
• High-dose testosterone reduced risky choices in gonadectomized males; estradiol had no significant effect.
• Amphetamine increased risky decision-making in intact rats but not in gonadectomized rats.

Conclusions:

• Males exhibit a greater bias towards larger, uncertain rewards compared to females.
• Gonadectomy status alters the dopaminergic regulation of risk-based choices.
• Findings highlight significant sex differences in hormonal and dopaminergic modulation of decision-making.